Translating epigenetic modulation of oncogenic pathways into first-in-class small molecule therapeutics
| Headquarters | Cambridge, MA |
| Website | https://www.k36tx.com/ |
| Pipeline Status | Preclinical |
| K36 Therapeutics |
K36 Therapeutics
Translating epigenetic modulation of oncogenic pathways into first-in-class small molecule therapeutics
| Headquarters | Cambridge, MA |
| Website | https://www.k36tx.com/ |
| Pipeline Status | Preclinical |
| K36 Therapeutics |